Here are links to Douglas Berger psychiatrist Tokyo websites, blogs and social media:
REVIEWS WEBSITE: Douglas-Berger-Psychiatrist-Tokyo-Reviews.com
ABOUT PAGE: About-Douglas-Berger-Psychiatrist-Tokyo.com/
INFORMATIONAL PAGE: Douglas-Berger-Psychiatrist-Tokyo-Info.com/
Marijuana medicinal products are very different from smoking pot-which cannot be good for psychiatric disorders: https://t.co/Sm1B473teN Author Moss has stock in GW Pharma, makers of marijuana derivative drugs. https://t.co/K6iHnNBhQ1
Some mistakenly think tramadol is a combination drug with both an opioid and an SNRI: https://t.co/kYtNeXyy9x Tramadol has a dual mechanism of action but it is not a combination drug. https://t.co/vhEwPF9JpC
Farah’s book on Hemingway had no interview & he/his estate gave no consent https://t.co/7y5FAs4cvY There's no brain scan/autopsy. Farah does not prove chronic traumatic encephalopathy nor disprove bipolar disorder. The estate may sue after sales grow. https://t.co/1HKbrH9Y6i #li
NIDA instills pot fear in doctors as causing schizophrenia & statements like "use and possession of cannabis is illegal in under federal law" etc: https://t.co/9LKyC7PDrw. Dr. Kosten is NIDA-sponsored & Psychiatric Times known to publish NIDA articles. https://t.co/vhEwPF9JpC #li
Questionable ethics when psychiatrists label persons they did not examine, here deceased poet Robert Lowell: https://t.co/KsJ2H0XRZE Psychiatric conditions are not provable so that (re)labeling Mr. Lowell is concerning even if his doctors did so. https://t.co/RZFx8zOZJO #li
ADHD is both over- and under-diagnosed, depending on the set of people you look at: https://t.co/wNPdlFMiUd The authors’ title “Are We Overdiagnosing and Overtreating ADHD?”, is somewhat unfair to the cohort of persons who are underdiagnosed. https://t.co/sJUSXfRv1G
Cold water swimming for depression https://t.co/rBHqTJW7bF What % and which depressives might benefit, is there placebo effect, what temp, duration, frequency is best is still unclear, & if this is reducing inflammation or stress response is conjecture. https://t.co/2opApRuwKL
There is confusion in depression with “full-remission” (no-symptoms), “effective” (defined at each use), and "responsive" (50% improvement) https://t.co/8g5BXeBjET Many trials claim efficacy using "responsive" but "responsive" is easy to achieve. Us: https://t.co/uZEIPRxr0J
Is there a list of CBT clinical trials for anxiety or depressive disorders that have had subject blinding or subject+treater blinding, or blind placebo? Rater blinding (often mistakenly called single-blind) is not so valuable as blind raters just record what the subject reports.
Funding longer GP consults seems ineffective for patients who are dead-set to get antibiotics. Funding public ads campaign, removing prescription repeats, and reducing prescription expiry to between 2 weeks and 3 months as noted in the article seems the way to go.